Waters Reports First Quarter 2013 Financial Results
News Apr 24, 2013
In the quarter, the effect of foreign currency translation reduced sales growth by 3%. On a GAAP basis, earnings per diluted share (E.P.S.) for the first quarter were $1.39 compared to $0.98 for the first quarter of 2012. On a non-GAAP basis, E.P.S. increased 7% to $1.07 compared to $1.00 in the prior year quarter. A description and reconciliation of GAAP to non-GAAP E.P.S. can be found on the Company’s website at http://www.waters.com under the caption Investors.
Commenting on the quarter, Douglas A. Berthiaume, Chairman, President, and Chief Executive Officer, said, “Constant currency sales growth was in line with our expectations and generally stronger than in recent quarters. We are encouraged by demand trends for new instrument systems, especially in China and India, and feel that positive business momentum across our major markets is sustainable.”
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE
Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule InhibitorsNews
A new original research article presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.READ MORE